Ling, X., Wu, W., Yan, L., Curtin, L., Farrauto, M. M., Sexton, S., . . . Li, F. Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer. Elsevier.
Chicago Style (17th ed.) CitationLing, Xiang, et al. Clinically and Orally Compatible Formulation-manufactured DDX5 (p68)-targeting Molecular Glue FL118 Products Exhibit Low Toxicity But high Efficacy Against Human Cancer. Elsevier.
MLA (9th ed.) CitationLing, Xiang, et al. Clinically and Orally Compatible Formulation-manufactured DDX5 (p68)-targeting Molecular Glue FL118 Products Exhibit Low Toxicity But high Efficacy Against Human Cancer. Elsevier.
Warning: These citations may not always be 100% accurate.